In any Texas drug case (whether arising from a probation drug test, a workplace test, or a drug possession arrest) understanding the difference between a screening test and a confirmatory test is foundational. These are not two names for the same thing. They are two different analytical processes with different purposes, different reliability characteristics, different error rates, and different legal significance.
The failure to understand this distinction leads to serious consequences: people who test positive on a screening test assume they are guilty when a confirmatory test might produce a very different result. Defendants plead guilty based on evidence that would not withstand scientific scrutiny if challenged. Probation violations are alleged based on results that have not been adequately confirmed.
Screening Tests: Speed Over Specificity
A drug screening test is a presumptive test which means it’s one designed to identify samples that are likely to contain a controlled substance so that they can be submitted for confirmatory analysis. Screening tests are designed for high sensitivity: they are calibrated to produce a positive result whenever there is any reasonable possibility that the target substance is present. The tradeoff is specificity: screening tests generate false positives from substances that are chemically similar to the target analyte but are not the controlled substance itself.
Immunoassay screening tests (the most commonly used screening method for urine drug testing) work by measuring whether a sample contains antibodies that bind to the target analyte. Many legal substances can trigger a positive immunoassay result because they share structural features with the controlled substance the test is designed to detect. Documented immunoassay cross-reactants include:
- THC immunoassays: NSAIDs such as ibuprofen and naproxen can cause false positives in some immunoassay systems at high doses.
- Amphetamine immunoassays: Pseudoephedrine, phenylephrine, selegiline, trazodone, and various prescription medications have been documented to cross-react with amphetamine immunoassays.
- Opioid immunoassays: Rifampin (a common antibiotic), dextromethorphan (an OTC cough suppressant), and quinolone antibiotics have been associated with false positive opioid screens in some systems.
- Benzodiazepine immunoassays: Sertraline (Zoloft) and oxaprozin have been documented to cause false positive benzodiazepine screens.
- PCP immunoassays: Venlafaxine (Effexor), dextromethorphan, and tramadol have been associated with false positive PCP results.
The essential point: a positive immunoassay screen does not mean a controlled substance is present. It means confirmatory testing is required.
Confirmatory Tests: Specificity Over Speed
Confirmatory testing, which is typically gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), identifies compounds based on their molecular structure and produces a quantitative result at a specific cutoff. These methods are not subject to the cross-reactivity that affects immunoassay screens because they measure the physical and chemical properties of specific molecules, not antibody binding.
A properly performed and validated GC-MS confirmatory test for THC-COOH (the primary urine metabolite of cannabis) will not produce a positive result from ibuprofen, because ibuprofen does not have the same mass spectrum as THC-COOH and does not elute at the same retention time. The specificity of GC-MS is what makes it the accepted confirmatory method but it must be properly performed and validated to produce reliable results.
The Two-Test Requirement
In recognized drug testing programs (ex. federal workplace testing under DOT regulations) a specimen cannot be reported positive unless both the screening test and the confirmatory test are positive, each at the applicable cutoff concentration. A specimen that is positive on the immunoassay screen but negative (or below the cutoff) on GC-MS confirmation is reported as negative.
This two-test requirement exists precisely because screening tests are known to produce false positives. The confirmatory test is not an afterthought. It is the scientifically valid result. The screen is a preliminary filter.
The Legal Significance
Probation and supervision violations. In Texas probation and bond supervision contexts, drug testing conditions are enforced based on positive test results. Whether the testing program requires confirmatory testing before a violation is alleged varies by court and supervision program. A defendant who tests positive on a screening test but whose confirmatory result is negative (or who was never given a confirmatory test) has a legitimate scientific challenge to the violation allegation.
Criminal drug cases. In a criminal prosecution for drug possession, the controlled substance must be identified through a validated analytical method that meets forensic standards. A preliminary field test or an immunoassay screen, standing alone, is not sufficient to establish the identity of a controlled substance for criminal conviction purposes. The prosecution must present a confirmatory analysis, and that analysis must be performed using a validated method by a qualified analyst with a complete chain of custody.
Workplace and licensing contexts. Professionals facing employment consequences or licensing actions based on a positive drug test are entitled to insist on confirmatory testing before any adverse action is taken. Confirmatory testing on a properly preserved split specimen is the standard in federally regulated testing programs and should be the standard in any context where the consequences are significant.
What to Do When You Have a Positive Screening Result
Request confirmatory testing immediately. Do not accept the consequences of a positive screening test without demanding the confirmatory analysis. Review your medications and supplements with your attorney, including over-the-counter products, because some are documented to cause false positive screens. Ensure that the confirmatory test is performed on a properly preserved specimen from the same collection, not a new sample. Review the confirmatory test results with your attorney and, in significant cases, have those results independently evaluated by a forensic toxicologist.
If forensic science evidence is central to your case, contact Deandra Grant Law for a free, confidential consultation. Managing Partner Deandra Grant and Partner Douglas Huff both hold the ACS-CHAL Forensic Lawyer-Scientist designation and Deandra has a Master’s Degree in Pharmaceutical Science and a Graduate Certificate in Forensic Toxicology. Call (214) 225-7117 or visit deandragrantlaw.com.